Ongoing treatment(s)-Bone marrow transplant Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Bone marrow transplant Posts on Medivizor

Testosterone levels in male patients with acute myeloid leukemia undergoing stem cell transplantation

Posted by on Jul 31, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of testosterone levels before a stem cell transplantation (SCT) on outcomes in male patients with acute myeloid leukemia (AML).    This study concluded that testosterone levels may predict the outcomes of these patients.  Some background Testosterone is a male...

Read More

Busulfan and fludarabine before transplant in the treatment of older patients with acute myeloid leukemia

Posted by on Jul 14, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effectiveness of busulfan (Busilvex) and fludarabine (Fludara) before transplant in the treatment of older patients with acute myeloid leukemia (AML). Researchers found that this treatment was safe and effective in these patients. Some background Acute myeloid leukemia is a cancer of the bone marrow. It...

Read More

Stem cell transplant and TKI treatment in patients with chronic myeloid leukemia

Posted by on May 26, 2019 in Leukemia | 0 comments

In a nutshell This study looked at stem cell transplant and tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The study found that stem cell transplant is still an effective treatment in certain patients with CML. Some background CML is a cancer of the immune system. It may lead to abnormal immune cells. It is...

Read More

Searching for patients with lymphoma or leukemia to test T-cell therapy after stem cell transplantation

Posted by on May 24, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This phase 2 trial is evaluating how well CD8+ memory T-cell therapy works in patients with leukemia or lymphoma after a stem cell transplant (SCT). The main outcome to be measured will be the number of patients who have full chimerism (donor cells work completely and only donor cells can be identified after transplant) after therapy. This...

Read More

What role does the graft-versus-leukemia effect have on survival in acute lymphoblastic leukemia?

Posted by on Mar 20, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of graft-versus-leukemia effect on survival in patients with acute lymphoblastic leukemia. This study concluded that graft-versus-leukemia effect was beneficial in certain subsets of these patients. Some background Allogeneic hematopoietic stem cell transplant (allo-HSCT) is a potentially...

Read More

Evaluating BEAM conditioning for allogeneic stem cell transplantation in patients with relapsed or unresponsive lymphoma

Posted by on Jan 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of BEAM (carmustine, etoposide, cytarabine, and melphalan) chemotherapy before allogeneic hematopoietic cell transplantation (alloHCT; transferring healthy cells from a donor) for relapsed or unresponsive lymphoma. This study concluded that alloHCT with BEAM chemotherapy is an alternative...

Read More

Evaluating the impact of early PET/CT scanning on survival in patients with lymphoma after stem cell transplant

Posted by on Dec 27, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the impact of early FDG PET/CT scanning on the survival of patients with lymphoma after allogeneic stem cell transplantation (alloSCT). This study concluded that having positive scan results at 3 months after alloSCT may highly predict relapse and poor survival in these patients. Some background An alloSCT is a...

Read More

Evaluating the impact of older age on patient outcomes after allogenic stem cell transplantation for NHL

Posted by on Oct 27, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the impact of older age on the outcomes of patients with non-Hodgkin’s lymphoma (NHL) who underwent allogeneic stem cell transplantation (alloSCT). This study concluded that alloSCT in patients older than 65 was associated with higher risks. Some background More than 60% of patients with NHL are older than...

Read More

Evaluating BendaEAM chemotherapy before stem cell transplantation for relapsed lymphoma

Posted by on Sep 28, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of the BendaEAM (bendamustine, etoposide, cytarabine, melphalan) in patients with lymphoma undergoing autologous stem cell transplantation (auto-SCT). This study concluded that BendaEAM is a feasible option for these patients, with minimal side effects. Some background High-dose...

Read More

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

Posted by on Sep 4, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the risk of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) development in patients with lymphoma and myeloma after an autologous stem cell transplant (autoSCT). This study concluded that this risk is quite high after autoSCT in these patients. Some background AML and MDS are known long-term...

Read More